Jiannan Yao - Publications

Targeting enolase isoenzyme 2 enables precision glycolysis inhibition in VHL-mutant renal cell carcinoma.

Journal: Cell death & disease

Published: December 13, 2025

Predicting Efficacy of Neoadjuvant Immunotherapy in Lung Cancer based on Tertiary Lymphoid Structure and Multi-Instance Learning.

Journal: Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference

Published: December 03, 2025

Testican-1 activates Wnt/β-Catenin signaling to drive colorectal cancer progression.

Journal: Oncogenesis

Published: November 04, 2025

Repurposed ethoxzolamide reprograms antitumor immunity through β-TrCP-dependent PD-L1 ubiquitination.

Journal: Cell reports. Medicine

Published: August 16, 2025

Retraction Note: Dclk1, a tumor stem cell marker, regulates pro-survival signaling and self-renewal of intestinal tumor cells.

Journal: Molecular cancer

Published: April 19, 2025

Hypoxic stimulation of DCLK1 transcription and alternative-promoter switching fuels tumor malignancy in clear cell renal cell carcinoma.

Journal: Cell death & disease

Published: November 25, 2024

Restoration of A2M reduces drug resistance and malignancy in paclitaxel-resistant lung cancer cells.

Journal: The international journal of biochemistry & cell biology

Published: November 04, 2024

Prognostic Signature in Osteosarcoma Based on Amino Acid Metabolism-Associated Genes.

Journal: Cancer biotherapy & radiopharmaceuticals

Published: March 21, 2024

GGT5: a potential immunotherapy response inhibitor in gastric cancer by modulating GSH metabolism and sustaining memory CD8+ T cell infiltration.

Journal: Cancer immunology, immunotherapy : CII

Published: November 03, 2023

Corrigendum to "Construction of a novel immune response prediction signature to predict the efficacy of immune checkpoint inhibitors in clear cell renal cell carcinoma patients" Heliyon 9(6), (May 25, 2023).

Journal: Heliyon

Published: July 19, 2023

MTA1 localizes to the mitotic spindle apparatus and interacts with TPR in spindle assembly checkpoint regulation.

Journal: Biochemical and biophysical research communications

Published: July 06, 2023

Selected cutaneous adverse events in patients treated with ICI monotherapy and combination therapy: a retrospective pharmacovigilance study and meta-analysis.

Journal: Frontiers in pharmacology

Published: October 21, 2022